Structures by: Palma A.
Total: 129
(2<i>S</i>,4<i>R</i>)-8-Chloro-9-methyl-2-<i>exo</i>-(1-naphthyl)-2,3,4,5- tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C21H18ClNO
Acta Crystallographica Section C (2010) 66, 11 o540-o546
a=7.4394(7)Å b=14.498(3)Å c=15.136(3)Å
α=90.00° β=90.00° γ=90.00°
(2<i>S</i>*,4<i>R</i>*)-2-<i>exo</i>-(1-Naphthyl)-2,3,4,5-tetrahydro- 1<i>H</i>-1,4-epoxy-1-benzazepine
C20H17NO
Acta Crystallographica Section C (2010) 66, 11 o540-o546
a=8.974(4)Å b=7.1817(8)Å c=22.718(9)Å
α=90.00° β=95.39(3)° γ=90.00°
2-Amino-6-methoxy-4-(4-methylanilino)-5-nitrosopyrimidine
C12H13N5O2
Acta Crystallographica Section C (2012) 68, 5 o199-o203
a=6.975(2)Å b=7.4704(10)Å c=12.161(4)Å
α=102.90(2)° β=92.64(3)° γ=101.144(19)°
7-bromo-2-<i>exo</i>-(2-chlorophenyl)-2,3,4,5-tetrahydro- 1,4-epoxynaphtho[1,2-<i>b</i>]azepine
C20H15BrClNO
Acta Crystallographica Section C (2012) 68, 3 o123-o125
a=11.5083(8)Å b=8.1027(6)Å c=18.3210(16)Å
α=90.00° β=110.505(5)° γ=90.00°
2-<i>exo</i>-(5-nitrofuran-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy- 1<i>H</i>-1-benzazepine
C14H12N2O4
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=7.2248(5)Å b=18.1447(19)Å c=9.4504(8)Å
α=90.00° β=94.279(6)° γ=90.00°
7-fluoro-2-<i>exo</i>-(1-methyl-1<i>H</i>-pyrrol-2-yl)-2,3,4,5-tetrahydro- 1,4-epoxy-1<i>H</i>-1-benzazepine
C15H15FN2O
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=27.141(4)Å b=5.4082(7)Å c=17.2849(18)Å
α=90.00° β=103.275(9)° γ=90.00°
7-fluoro-2-<i>exo</i>-(5-methylfuran-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy- 1<i>H</i>-1-benzazepine
C15H14FNO2
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=5.5265(5)Å b=10.6652(19)Å c=20.905(4)Å
α=90.00° β=97.166(11)° γ=90.00°
7-fluoro-2-<i>exo</i>-(3-methylthiophen-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy- 1<i>H</i>-1-benzazepine
C15H14FNOS
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=9.272(2)Å b=10.9142(13)Å c=12.963(2)Å
α=90.00° β=101.023(11)° γ=90.00°
7-chloro-2-<i>exo</i>-(5-methylfuran-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy- 1<i>H</i>-1-benzazepine
C15H14ClNO2
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=10.2835(13)Å b=5.4829(3)Å c=23.428(2)Å
α=90.00° β=96.665(9)° γ=90.00°
7-fluoro-2-<i>exo</i>-(5-methylthiophen-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy- 1<i>H</i>-1-benzazepine
C15H14FNOS
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=9.2106(16)Å b=10.906(2)Å c=13.4259(13)Å
α=90.00° β=106.086(12)° γ=90.00°
2-<i>exo</i>-(3-methylthiophen-2-yl)-7-trifluoromethoxy-2,3,4,5-tetrahydro- 1,4-epoxy-1<i>H</i>-1-benzazepine
C16H14F3NO2S
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=16.234(3)Å b=5.6113(5)Å c=16.665(3)Å
α=90.00° β=106.143(14)° γ=90.00°
2-<i>exo</i>-(5-nitrofuran-2-yl)-7-trifluoromethoxy-2,3,4,5-tetrahydro-1,4- epoxy-1<i>H</i>-1-benzazepine
C15H11F3N2O5
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=20.4120(15)Å b=7.3690(18)Å c=10.035(3)Å
α=90.00° β=103.091(15)° γ=90.00°
<i>cis</i>-(2<i>RS</i>,4<i>SR</i>)-2-(thiophen-2-yl)-2,3,4,5-tetrahydro- 1<i>H</i>-1-benzazepin-4-ol
C14H15NOS
Acta Crystallographica Section C (2012) 68, 3 o126-o130
a=9.5677(6)Å b=9.8798(4)Å c=14.7183(11)Å
α=104.726(5)° β=104.033(6)° γ=103.273(4)°
<i>cis</i>-(2<i>RS</i>,4<i>SR</i>)-2-(5-methylthiophen-2-yl)-2,3,4,5-tetrahydro- 1<i>H</i>-1-benzazepin-4-ol
C15H17NOS
Acta Crystallographica Section C (2012) 68, 3 o126-o130
a=9.6764(5)Å b=10.6897(3)Å c=14.4433(5)Å
α=72.018(3)° β=89.108(3)° γ=72.494(3)°
Ethyl <i>N</i>-[4-(adamantan-1-ylamino)-2-amino-5-nitrosopyrimidin-6-yl]-3- aminopropionate
C19H28N6O3
Acta Crystallographica Section C (2012) 68, 5 o199-o203
a=11.6250(12)Å b=13.2225(11)Å c=13.0172(13)Å
α=90.00° β=101.920(8)° γ=90.00°
(2<i>RS</i>,4<i>RS</i>)-7-Fluoro-2-(2-phenylethyl)-2,3,4,5-tetrahydro- 1<i>H</i>-1,4-epoxy-1-benzazepine
C18H18FNO
Acta Crystallographica Section C (2012) 68, 5 o195-o198
a=9.6285(4)Å b=11.2875(5)Å c=13.5147(6)Å
α=90.00° β=99.565(3)° γ=90.00°
(2<i>RS</i>,4<i>RS</i>)-7-chloro-2-(2-phenylethyl)-2,3,4,5-tetrahydro- 1<i>H</i>-1,4-epoxy-1-benzazepine
C18H18ClNO
Acta Crystallographica Section C (2012) 68, 5 o195-o198
a=10.0891(10)Å b=10.981(2)Å c=13.7952(18)Å
α=90.00° β=92.771(11)° γ=90.00°
(<i>E</i>)-3-Acetyl-2-methyl-4-[4-(trifluoromethyl)styryl]quinoline
C21H16F3NO
Acta Crystallographica Section C (2020) 76, 9
a=8.0822(4)Å b=6.6567(4)Å c=32.1024(17)Å
α=90° β=90.576(2)° γ=90°
4-(1<i>H</i>-Benzo[<i>d</i>]imidazol-1-yl)-6,11-dimethyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine 0.374-hydrate
C21H19N5,0.374(H2O)
Acta Crystallographica Section C (2018) 74, 3
a=11.1086(5)Å b=8.7806(3)Å c=17.7753(9)Å
α=90° β=103.651(2)° γ=90°
3-Acetyl-8-allyl-6-methyl-2-phenylquinolin-4-yl acetate
C23H21NO3
Acta Crystallographica Section C (2016) 72, 8
a=9.0386(9)Å b=8.2036(8)Å c=25.119(3)Å
α=90° β=96.385(10)° γ=90°
(2<i>SR</i>,4<i>RS</i>)-8,9-Dimethyl-2-(naphthalen-1-yl)-2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C22H21NO
Acta Crystallographica Section C (2016) 72, 5 363-372
a=7.2201(2)Å b=7.8128(3)Å c=14.7409(5)Å
α=90° β=93.690(2)° γ=90°
(2<i>RS</i>,5<i>SR</i>)-8-(trifluoromethoxy)-5,6-dihydro-1<i>H</i>-2,5-methanobenz[<i>e</i>][1,4]oxazocin-3(2<i>H</i>)-one
C12H10F3NO3
Acta Crystallographica Section C (2014) 70, 4 408-415
a=15.0601(8)Å b=9.2204(5)Å c=8.072(4)Å
α=90.00° β=91.668(10)° γ=90.00°
Ethyl 3-amino-<i>N</i>-{2-amino-6-[benzyl(methyl)amino]-5-formylpyrimidin- 4-yl}propionate
C18H23N5O3
Acta Crystallographica Section C (2013) 69, 2 162-171
a=24.8226(5)Å b=7.1379(14)Å c=20.601(2)Å
α=90.00° β=106.213(8)° γ=90.00°
7-chloro-4-hydroxy-2-vinyl-2,3,4,5-tetrahydro-1-benzazepine
C12H14ClNO
Acta Crystallographica Section C (2009) 65, 3 o92-o96
a=11.0850(7)Å b=7.4214(10)Å c=13.4588(11)Å
α=90.00° β=94.721(8)° γ=90.00°
(2<i>SR</i>,4<i>RS</i>)-7-chloro-2-<i>exo</i>-(2-chloro-6-fluorophenyl)- 2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C16H12Cl2FNO
Acta Crystallographica Section C (2009) 65, 9 o465-o469
a=9.2907(11)Å b=10.8720(9)Å c=13.4523(13)Å
α=90.00° β=95.964(8)° γ=90.00°
(2<i>SR</i>,4<i>RS</i>)-7-Methyl-2-<i>exo</i>-(1-naphthyl)-2,3,4,5-tetrahydro- 1<i>H</i>-1,4-epoxy-1-benzazepine
C21H19NO
Acta Crystallographica Section C (2010) 66, 11 o540-o546
a=10.7760(13)Å b=8.9612(11)Å c=15.4241(15)Å
α=90.00° β=96.799(10)° γ=90.00°
2-<i>exo</i>-(5-methylfuran-2-yl)-7-trifluoromethoxy-2,3,4,5-tetrahydro- 1,4-epoxy-1<i>H</i>-1-benzazepine
C16H14F3NO3
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=5.5088(6)Å b=10.7619(17)Å c=13.1398(19)Å
α=110.011(10)° β=98.797(10)° γ=92.271(12)°
C18H24ClNO2
C18H24ClNO2
Powder Diffraction (1999) 14, 249-252
a=14.4710Å b=9.6000Å c=11.9480Å
α=90.000° β=93.210° γ=90.000°
C17H21Cl2NO
C17H21Cl2NO
Powder Diffraction (1999) 14, 249-252
a=14.4870Å b=9.8780Å c=11.3900Å
α=90.000° β=91.660° γ=90.000°